77.4 F
New York
Thursday, July 29, 2021

Tiziana [NASDAQ: TLSA] Submits Patent Application For Use Of Foralumab In COVID-19

Must read

Digital Realty [NYSE: DLR] Considering Developing 64 MW Facility in South Korea

Digital Realty Trust, Inc. has shown its intention to build the 64-megawatt facility in Seoul, South Korea. The firm has decided that the...

Why Shares of IZEA Worldwide [NASDAQ: IZEA] Skyrocketing Today?

Shares of IZEA Worldwide, Inc. surged 8.10% at the time of writing on Wednesday. The strong performance of the firm has highlighted the...

BIT Mining [NYSE: BTCM] Ink Purchase Agreement to Buy Bitcoin Mining Machine

BIT Mining Limited has inked a purchase agreement to increase the fleet of bitcoin mining machines. As per the new purchase agreement, the...

Dyadic International [NASDAQ: DYAI] Inks Licensing Agreement with the Rubic Consortium

Dyadic International, Inc. disclosed that it has inked a COVID-19 vaccine technology transfer and licensing agreement with the Rubic Consortium. It has been...

Tiziana Life Sciences PLC [NASDAQ: TLSA] disclosed today it has submitted an application for the use of Foralumab in the treatment of COVID-19. The combination of anti-viral & anti-inflammatory drugs proven to be very useful in the treatment of COVID-19 patients at different stages, recent clinical studies suggested.

Foralumab is known as NI-0401 is a fully-human monoclonal anti-CD3 antibody which is developed for the treatment of autoimmune & inflammatory diseases.

Foralumab nasal administration has the potential to improve the immune system. It also has the ability to put down the cytokines storm and decrease respiratory failure in COVID-19 patients. Foralumab nasal administration when combined with other anti-viral drugs plays an important role in improving treatment efficacy.

Shares of Tiziana soared 19.06% at $12.37 during the trading of Thursday. It had trading volume of 1.6 million as compared to the average volume of 305.68K. Tiziana has total market capitalization of 411.70 million.

In the past 52-weeks of trading, this company’s stocks have fluctuated between the low of $1.54 and a high of $12.61. It has moved up 703.25% from 52-weeks low and moved down -1.90% from its 52-weeks high.

A biotechnology company has a worldwide license for the nasal administration of Foralumab and other anti CD3 mAbs for the treatment of various diseases. Earlier, Tiziana has developed the nasal spray device using Foralumab. The firm has also disclosed the successful completion Phase 1 trial with the oral administration of Foralumab.

More articles

Latest article

Binance, FTX Cut Leverage Limits on Crypto Futures Trading to 20x

Two major cryptocurrency trading platforms Binance Futures and FTX disclosed on Monday that they both have made a remarkable decision related to the crypto...

TD Holdings [NASDAQ: GLG] Inks Letter of Intent with Guangdong Jinbochuang

TD Holdings, Inc. has inked a letter of intent (LOI) with Guangdong Jinbochuang Special Purpose Vehicle Co., Ltd. and (Jinbochuang) and Hunan Jinmeike...

ASGN [NYSE: ASGN] Acquire IndraSoft Inc

ASGN Incorporated disclosed that it has acquired IndraSoft Inc. IndraSoft Inc has gained recognition as a prominent cybersecurity and digital transformation solutions offeror...

Link Reservations Decides to Accept Bitcoin/Crypto Payments

Link Reservations Inc disclosed Friday that it has decided to start accepting Bitcoin and cryptocurrency payments. This is the major breakthrough for the firm...

Athene [NYSE: ATH] Announces Acquisition of Foundation Home Loans

Athene Holding Ltd. disclosed on Thursday that it has inked a definitive agreement to purchase Foundation Home Loans (FHL). FHL had a £3...

Ping [NYSE: PING] and Anexinet Announces Partnership

Ping Identity Holding Corp. and Anexinet Corporation have both entered into a partnership agreement. The collaboration will integrate Ping Identity’s centralized Identity Access...

Digital Realty [NYSE: DLR] and Brookfield Announces Joint Venture

Digital Realty Trust, Inc.   and Brookfield Infrastructure Partners L.P. and its institutional partners disclosed on Wednesday that they have launched a 50/50 joint...

Red Cat [NASDAQ: RCAT] Announces Acquisition of Teal Drones

Red Cat Holdings, Inc. has inked an agreement on Tuesday to buy Teal Drones in an all-stock transaction. This acquisition will add Teal...